Hasil Pencarian - Lisa Vandermeer
- Menampilkan 1 - 20 hasil dari 24
- Ke Halaman Berikutnya
-
1
-
2
-
3
The Rethinking Clinical Trials (REaCT) Program. A Canadian-Led Pragmatic Trials Program: Strategies for Integrating Knowledge Users into Trial Design oleh Deanna Saunders, Michelle Liu, Lisa Vandermeer, Mashari Jemaan Alzahrani, Brian Hutton, Mark Clemons
Diterbitkan 2021-10-01
Artikel -
4
Randomised feasibility trial to compare three standard of care chemotherapy regimens for early stage triple-negative breast cancer (REaCT-TNBC trial). oleh John Hilton, Carol Stober, Sasha Mazzarello, Lisa Vandermeer, Dean Fergusson, Brian Hutton, Mark Clemons
Diterbitkan 2018-01-01
Artikel -
5
-
6
Shorter Durations of Anti-HER2 Therapy for Patients with Early-Stage, HER2-Positive Breast Cancer: The Physician Perspective oleh Michelle Bradbury, Marie-France Savard, Lisa Vandermeer, Lucas Clemons, Gregory Pond, John Hilton, Mark Clemons, Sharon McGee
Diterbitkan 2023-12-01
Artikel -
7
-
8
Real-world practice patterns and attitudes towards de-escalation of bone-modifying agents in patients with bone metastases from breast and prostate cancer: A physician survey oleh Mashari AlZahrani, Mark Clemons, Lisa Vandermeer, Marta Sienkiewicz, Arif Ali Awan, Brian Hutton, Gregory R. Pond, Terry L. Ng
Diterbitkan 2021-02-01
Artikel -
9
Regularly scheduled physical examinations and the detection of breast cancer recurrences oleh Ana-Alicia Beltran-Bless, Bader Alshamsan, Mashari Jemaan Alzahrani, John Hilton, Kelly-Anne Baines, Vicky Samuel, Gregory R. Pond, Lisa Vandermeer, Mark Clemons, Gail Larocque
Diterbitkan 2023-06-01
Artikel -
10
A Multi-Centre Randomized Study Comparing Two Standard of Care Chemotherapy Regimens for Lower-Risk HER2-Positive Breast Cancer oleh Ricardo Fernandes, Terry L. Ng, Mashari Jemaan Alzahrani, Jacques Raphael, Phillip Blanchette, Morgan Black, Carol Stober, Gregory R. Pond, David Cella, Lisa Vandermeer, Mohammed Ibrahim, Mark Clemons
Diterbitkan 2023-08-01
Artikel -
11
Primary Febrile Neutropenia Prophylaxis for Patients Who Receive FEC-D Chemotherapy for Breast Cancer: A Systematic Review oleh Ricardo Fernandes, Sasha Mazzarello, Carol Stober, Mohamed F.K. Ibrahim, Shaan Dudani, Kirstin Perdrizet, Habeeb Majeed, Lisa Vandermeer, Risa Shorr, Brian Hutton, Dean Fergusson, Bishal Gyawali, Mark Clemons
Diterbitkan 2017-04-01
Artikel -
12
Oral magnesium supplements for cancer treatment‐induced hypomagnesemia: Results from a pilot randomized trial oleh Arif Awan, Bassam Basulaiman, Carol Stober, Mark Clemons, Dean Fergusson, John Hilton, Waleed Al Ghareeb, Rachel Goodwin, Mohammed Ibrahim, Brian Hutton, Lisa Vandermeer, Ranjeeta Mallick, Michael M. Vickers
Diterbitkan 2021-12-01
Artikel -
13
Does Pre-Emptive Availability of PREDICT 2.1 Results Change Ordering Practices for Oncotype DX? A Multi-Center Prospective Cohort Study oleh Arif Ali Awan, Deanna Saunders, Gregory Pond, Caroline Hamm, Nadia Califaretti, Mihaela Mates, Vikaash Kumar, Mohammed F. K. Ibrahim, Ana-Alicia Beltran-Bless, Lisa Vandermeer, John Hilton, Mark Clemons
Diterbitkan 2024-02-01
Artikel -
14
Cost-Effectiveness Analysis of 12-Versus 4-Weekly Administration of Bone-Targeted Agents in Patients with Bone Metastases from Breast and Castration-Resistant Prostate Cancer oleh Megan M. Tu, Mark Clemons, Carol Stober, Ahwon Jeong, Lisa Vandermeer, Mihaela Mates, Phillip Blanchette, Anil Abraham Joy, Olexiy Aseyev, Gregory Pond, Dean Fergusson, Terry L. Ng, Kednapa Thavorn
Diterbitkan 2021-05-01
Artikel -
15
Experiences and Perceptions of Older Adults with Lower-Risk Hormone Receptor-Positive Breast Cancer about Adjuvant Radiotherapy and Endocrine Therapy: A Patient Survey oleh Marie-France Savard, Mashari Jemaan Alzahrani, Deanna Saunders, Lynn Chang, Angel Arnaout, Terry L. Ng, Muriel Brackstone, Lisa Vandermeer, Tina Hsu, Ari Ali Awan, Katherine Cole, Gail Larocque, Mark Clemons
Diterbitkan 2021-12-01
Artikel -
16
Feasibility outcomes of a randomised, multicentre, pilot trial comparing standard 6-monthly dosing of adjuvant zoledronate with a single one-time dose in patients with early stage... oleh Arif Awan, Terry Ng, Henry Conter, William Raskin, Carol Stober, Demetrios Simos, Greg Pond, Sukhbinder Dhesy-Thind, Mihaela Mates, Vikaash Kumar, Dean Fergusson, Brian Hutton, Deanna Saunders, Lisa Vandermeer, Mark Clemons
Diterbitkan 2021-02-01
Artikel -
17
Adjuvant bisphosphonate use in patients with early stage breast cancer: Patient perspectives on treatment acceptability and potential de-escalation oleh Sharon McGee, Mashari AlZahrani, Carol Stober, Terry L. Ng, Katherine Cole, Gail Larocque, Arif Awan, Sandeep Sehdev, John Hilton, Lisa Vandermeer, Brian Hutton, Gregory Pond, Deanna Saunders, Mark Clemons
Diterbitkan 2021-04-01
Artikel -
18
The REthinking Clinical Trials Program Retreat 2023: Creating Partnerships to Optimize Quality Cancer Care oleh Ana-Alicia Beltran-Bless, Mark Clemons, Lisa Vandermeer, Khaled El Emam, Terry L. Ng, Sharon McGee, Arif Ali Awan, Gregory Pond, Julie Renaud, Gwen Barton, Brian Hutton, Marie-France Savard
Diterbitkan 2024-03-01
Artikel -
19
A Randomized Controlled Trial Comparing Alloderm-RTU with DermACELL in Immediate Subpectoral Implant-Based Breast Reconstruction oleh Angel Arnaout, Jing Zhang, Simon Frank, Moein Momtazi, Erin Cordeiro, Amanda Roberts, Ammara Ghumman, Dean Fergusson, Carol Stober, Gregory Pond, Ahwon Jeong, Lisa Vandermeer, Brian Hutton, Mark Clemons, on behalf of the REaCT Investigators
Diterbitkan 2020-12-01
Artikel -
20
Optimising weight-loss interventions in cancer patients-A systematic review and network meta-analysis. oleh Nathalie LeVasseur, Wei Cheng, Sasha Mazzarello, Mark Clemons, Lisa Vandermeer, Lee Jones, Anil Abraham Joy, Pauline Barbeau, Dianna Wolfe, Nadera Ahmadzai, Mona Hersi, Carol Stober, Risa Shorr, John Hilton, Brian Hutton
Diterbitkan 2021-01-01
Artikel